Reply to Y. Myoken et al

Affiliations

¹ Ie-Wen Sim, MBBS(Hons), BMedSci, FRACP, Melbourne Medical School, University of Melbourne, Melbourne, Australia, Department of Medicine, School of Clinical Sciences, Monash University, Melbourne, Australia; Gelsomina L. Borromeo, BDSc, BSc, MScMed, PhD, FRACDS, Melbourne Dental School, University of Melbourne, Melbourne, Australia; John F. Seymour, MBBS, PhD, FRACP, Melbourne Medical School, University of Melbourne, Melbourne, Australia, Department of Haematology, Peter MacCallum Cancer Centre & Royal Melbourne Hospital, Melbourne, Australia; and Peter R. Ebeling, MBBS, MD, FRACP, Department of Medicine, School of Clinical Sciences, Monash University, Melbourne, Australia.

Comment

Ie-Wen Sim et al. J Clin Oncol. 2021.

. 2021 Jan 10;39(2):173-174.

doi: 10.1200/JCO.20.02906. Epub 2020 Dec 8.

¹ Ie-Wen Sim, MBBS(Hons), BMedSci, FRACP, Melbourne Medical School, University of Melbourne, Melbourne, Australia, Department of Medicine, School of Clinical Sciences, Monash University, Melbourne, Australia; Gelsomina L. Borromeo, BDSc, BSc, MScMed, PhD, FRACDS, Melbourne Dental School, University of Melbourne, Melbourne, Australia; John F. Seymour, MBBS, PhD, FRACP, Melbourne Medical School, University of Melbourne, Melbourne, Australia, Department of Haematology, Peter MacCallum Cancer Centre & Royal Melbourne Hospital, Melbourne, Australia; and Peter R. Ebeling, MBBS, MD, FRACP, Department of Medicine, School of Clinical Sciences, Monash University, Melbourne, Australia.

No abstract available

Comment on

Teriparatide Promotes Bone Healing in Medication-Related Osteonecrosis of the Jaw: A Placebo-Controlled, Randomized Trial.
Sim IW, Borromeo GL, Tsao C, Hardiman R, Hofman MS, Papatziamos Hjelle C, Siddique M, Cook GJR, Seymour JF, Ebeling PR. Sim IW, et al. J Clin Oncol. 2020 Sep 10;38(26):2971-2980. doi: 10.1200/JCO.19.02192. Epub 2020 Jul 2. J Clin Oncol. 2020. PMID: 32614699 Clinical Trial.
Teriparatide Treatment for Medication-Related Osteonecrosis of the Jaw: Is This an Effective Option?
Myoken Y, Fujita Y, Toratani S. Myoken Y, et al. J Clin Oncol. 2021 Jan 10;39(2):172-173. doi: 10.1200/JCO.20.02379. Epub 2020 Dec 8. J Clin Oncol. 2021. PMID: 33290129 No abstract available.